PCC1 was also found to eliminate p16-positive senescent cells as effectively as ABT-263, in addition to its ability to increase tumor suppression, inhibit resistance to chemotherapy, and ameliorate physical dysfunction. This evidence concerns the gene CDKN2A and neoplasm.